OK Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	1,639	1,670	1,192	1,484	1,263	1,484
Revenue Growth (YoY)	7.49%	40.11%	-19.65%	17.42%	-14.89%	19.59%
Cost of Revenue	1,197	1,394	995.1	1,139	1,077	1,158
Gross Profit	442.83	275.66	196.88	344.96	186.83	325.96
Selling, General & Admin	263.63	177.25	148.41	156.09	148.24	152.14
Research & Development	49.5	57.93	46.71	48.73	28.74	45.46
Other Operating Expenses	-4.87	-6.29	-7.43	7.06	-4.93	-8.07
Operating Expenses	356.61	218.44	208.95	243.15	178.74	199.86
Operating Income	86.22	57.21	-12.06	101.81	8.09	126.1
Interest Expense	-9.88	-6.23	-9	-11.42	-8.08	-8.12
Interest & Investment Income	4.16	6.1	7.15	4.43	1.3	2.1
Earnings From Equity Investments	1.28	5.11	5.33	7.43	24.65	38.61
Currency Exchange Gain (Loss)	-12.77	49.28	-9.86	59.91	-9.19	-30.26
Other Non Operating Income (Expenses)	17.86	13.33	23.69	18.04	28.26	22.51
EBT Excluding Unusual Items	86.86	124.8	5.24	180.2	45.03	150.94
Impairment of Goodwill	-	-	-	-6	-	-
Gain (Loss) on Sale of Investments	2.2	-	-	-	0.19	-
Gain (Loss) on Sale of Assets	3.25	2.31	2.78	1.4	0.92	0.72
Pretax Income	92.31	127.11	8.03	175.59	46.14	151.66
Income Tax Expense	8.58	20.79	9.62	38.87	14.72	30.35
Earnings From Continuing Operations	83.73	106.32	-1.59	136.73	31.42	121.3
Minority Interest in Earnings	-14.99	-12.34	4.54	6.74	12.04	8.43
Net Income	68.75	93.98	2.95	143.46	43.46	129.73
Net Income to Common	68.75	93.98	2.95	143.46	43.46	129.73
Net Income Growth	196.92%	3087.75%	-97.95%	230.09%	-66.50%	3.16%
Shares Outstanding (Basic)	142	143	128	105	104	92
Shares Outstanding (Diluted)	144	146	128	130	118	100
Shares Change (YoY)	8.28%	14.02%	-1.41%	9.95%	18.84%	16.16%
EPS (Basic)	0.48	0.66	0.02	1.37	0.42	1.42
EPS (Diluted)	0.47	0.64	0.02	1.16	0.41	1.32
EPS Growth	198.47%	3119.04%	-98.28%	182.57%	-68.83%	-10.49%
Free Cash Flow	-302.89	-310.79	-426.74	-46.31	-57.16	67.91
Free Cash Flow Per Share	-2.10	-2.12	-3.32	-0.36	-0.48	0.68
Dividend Per Share	0.300	0.300	0.300	1.115	0.907	1.270
Dividend Growth	-	-	-73.11%	22.95%	-28.58%	-3.44%
Gross Margin	27.01%	16.51%	16.52%	23.25%	14.79%	21.96%
Operating Margin	5.26%	3.43%	-1.01%	6.86%	0.64%	8.49%
Profit Margin	4.19%	5.63%	0.25%	9.67%	3.44%	8.74%
Free Cash Flow Margin	-18.48%	-18.61%	-35.80%	-3.12%	-4.52%	4.58%
EBITDA	165.04	125.25	60.32	165.94	59.73	171.2
EBITDA Margin	10.07%	7.50%	5.06%	11.19%	4.73%	11.53%
D&A For EBITDA	78.82	68.04	72.38	64.13	51.64	45.1
EBIT	86.22	57.21	-12.06	101.81	8.09	126.1
EBIT Margin	5.26%	3.43%	-1.01%	6.86%	0.64%	8.49%
Effective Tax Rate	9.29%	16.36%	119.86%	22.13%	31.90%	20.01%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.